Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

VIMPAT™ tablets 100mg, 14pcs

🔥 2 items sold in last 3 hours
10 people are viewing this product
Brand:
Active Ingredient:

Manufacturer:

$37.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

VIMPAT™ tablets 150mg, 56pcs

$195.00
Add to cart

VIMPAT™ tablets 200mg, 56pcs

$262.00
Add to cart

Analogs of VIMPAT™

L-THYROXINE BERLIN-CHEMIE™ tablets 50mcg, 50pcs

$7.00
Add to cart

L-THYROXINE BERLIN-CHEMIE™ tablets 75mcg, 100pcs

$10.00
Add to cart

L-THYROXINE tablets 100mcg, 100pcs

$8.00
Add to cart

L-THYROXINE tablets 100mcg, 50pcs

$7.00
Add to cart

Table of Contents

VIMPAT™ 100mg Tablets Buy Online

Vimpat (Lacosamide): A Comprehensive Overview

Managing epilepsy effectively requires a multifaceted approach, and choosing the right medication is paramount. Vimpat, with its active ingredient lacosamide, plays a significant role in this process, offering a targeted solution for specific seizure types.

This overview provides a comprehensive understanding of Vimpat’s mechanism of action, its uses, and important safety considerations. Understanding these aspects empowers both patients and healthcare professionals to make informed decisions regarding treatment strategies.

While Vimpat is a powerful tool in epilepsy management, it’s crucial to remember that individual responses to medication vary. Always consult with your doctor to determine the suitability of Vimpat for your specific needs and circumstances.

Understanding Vimpat

Vimpat, containing the active ingredient lacosamide, is an anti-epileptic drug (AED), also known as an anticonvulsant. It’s specifically designed to help manage certain types of seizures by affecting the way nerve cells communicate in the brain. This modulation of nerve signals helps prevent or reduce the occurrence of seizures.

Unlike some other AEDs, lacosamide’s precise mechanism of action isn’t fully understood. However, research suggests it works by selectively enhancing slow inactivation of voltage-gated sodium channels. This complex process ultimately stabilizes the electrical activity within nerve cells, decreasing the likelihood of abnormal, seizure-causing discharges.

The medication is available in various forms, including tablets and oral solutions, allowing for flexibility in administration based on individual patient needs and preferences. Careful adherence to prescribed dosage and administration instructions is crucial for optimal therapeutic outcomes and minimizing potential side effects. Always consult with your physician or pharmacist for detailed guidance.

What is Vimpat?

Vimpat, a brand-name prescription medication, contains lacosamide as its active pharmaceutical ingredient. It is classified as an anti-epileptic drug (AED), also known as an anticonvulsant. This means its primary function is to control or prevent seizures in individuals with epilepsy. The precise mechanism of action, while not fully elucidated, involves influencing the way nerve cells communicate, thereby preventing the uncontrolled electrical activity that characterizes seizures.

Lacosamide works by selectively enhancing the slow inactivation of voltage-gated sodium channels in the central nervous system. This complex interaction helps stabilize the electrical activity within neurons, reducing the likelihood of abnormal discharges that trigger seizures. This targeted approach offers a potentially effective treatment option for specific types of epilepsy.

Importantly, Vimpat is not a cure for epilepsy; rather, it is a medication designed to manage symptoms. Its effectiveness varies among individuals, and the optimal dosage and treatment plan should always be determined in consultation with a healthcare professional experienced in epilepsy management. Regular monitoring and adjustments to the treatment plan may be necessary to optimize therapeutic outcomes.

How Vimpat Works

Vimpat’s mechanism of action, while not fully understood, centers on its interaction with voltage-gated sodium channels in neurons. These channels are crucial for the transmission of nerve impulses. Lacosamide, the active ingredient, selectively enhances the slow inactivation of these channels, a process that impacts the excitability of nerve cells.

By modifying the activity of these sodium channels, Vimpat helps to stabilize the electrical activity within neurons, preventing the uncontrolled firing that leads to seizures. This stabilization prevents the spread of abnormal electrical discharges across brain regions, thus reducing the likelihood and severity of seizures. The precise molecular details of this interaction remain an area of ongoing research.

It’s important to note that Vimpat does not directly target the underlying cause of epilepsy. Instead, it focuses on modulating the electrical activity within the brain to prevent or reduce the frequency and intensity of seizures. This targeted approach makes it a valuable tool in the management of specific seizure types, offering a potential benefit to many individuals with epilepsy.

Vimpat’s Uses in Seizure Management

Vimpat has demonstrated efficacy in managing specific types of seizures, making it a valuable tool in the arsenal of epilepsy treatments. Its primary application is in the treatment of partial-onset seizures, a common type of seizure that originates in a specific area of the brain. These seizures can manifest in various ways, from subtle sensory disturbances to more pronounced motor symptoms, depending on the affected brain region.

In addition to its effectiveness as a monotherapy for partial-onset seizures, Vimpat is also frequently used as adjunctive therapy. This means it’s employed alongside other anti-epileptic medications to enhance seizure control when a single drug isn’t sufficient. This combined approach often proves beneficial in achieving optimal seizure reduction for individuals whose epilepsy is not adequately controlled by a single AED.

The specific use of Vimpat, whether as monotherapy or adjunctive therapy, depends on factors such as the type of seizure, the patient’s individual response to medication, and other relevant medical considerations. Therefore, careful evaluation and collaboration between the patient and their neurologist are essential to determine the most appropriate treatment strategy and optimize therapeutic outcomes. The goal is always to minimize seizure frequency and improve the patient’s quality of life.

Treating Partial-Onset Seizures

Vimpat has proven particularly effective in managing partial-onset seizures, also known as focal seizures. These seizures originate in a specific area of the brain, and their symptoms vary widely depending on the location of the seizure focus. Symptoms can range from subtle sensory changes, such as unusual smells or tastes, to more pronounced motor symptoms like jerking movements or impaired speech.

Vimpat’s ability to target and modulate the electrical activity within the affected brain region makes it a valuable treatment option for many individuals experiencing partial-onset seizures. It works by stabilizing the electrical activity, preventing the abnormal discharges that trigger these seizures. This targeted approach minimizes the spread of abnormal activity, often reducing the severity and frequency of seizures.

The effectiveness of Vimpat in treating partial-onset seizures can vary depending on individual factors. Factors such as the severity of the epilepsy, the presence of other health conditions, and the patient’s response to the medication all play a role. Therefore, close monitoring by a healthcare professional is crucial to ensure optimal treatment and to adjust the medication regimen as needed to achieve the best possible seizure control.

Adjunctive Therapy for Tonic-Clonic Seizures

While primarily used for partial-onset seizures, Vimpat also plays a role in managing primary generalized tonic-clonic seizures (PGTCs), also known as grand mal seizures. In this context, Vimpat isn’t typically used as a standalone treatment but rather as adjunctive therapy, meaning it’s added to an existing anti-epileptic drug regimen.

For individuals whose PGTC seizures are not adequately controlled by their current medication, adding Vimpat can significantly improve seizure control. The combined action of Vimpat and other AEDs offers a synergistic effect, potentially reducing seizure frequency and severity more effectively than either medication alone. This combined approach is often tailored to individual patient needs.

The decision to use Vimpat as adjunctive therapy for PGTC seizures is made on a case-by-case basis, taking into account the patient’s specific seizure characteristics, response to other medications, and overall health status. Close monitoring by a neurologist is essential to assess the effectiveness of the combined therapy and make any necessary adjustments to the medication regimen. The ultimate goal is to optimize seizure control while minimizing potential side effects.

Dosage and Administration

The appropriate dosage of Vimpat is determined by a healthcare professional based on individual patient factors, including the type and severity of seizures, response to treatment, and overall health. It’s crucial to follow the prescribed dosage and administration instructions precisely to ensure efficacy and minimize the risk of side effects. Never adjust the dosage without consulting your physician.

Vimpat is typically administered orally, either as tablets or an oral solution. The medication can be taken with or without food. For those unable to take oral medication, intravenous administration may be considered under specific circumstances. The initial dosage is usually started low and gradually increased as tolerated to achieve optimal therapeutic effects.

Regular monitoring of blood levels may be undertaken to ensure the medication is within the therapeutic range. This regular monitoring helps to fine-tune the dosage to meet individual needs while minimizing the risk of adverse events. Remember, consistent adherence to the prescribed regimen is vital for achieving and maintaining effective seizure control. Any changes in dosage or administration should be discussed with your doctor.

Available Forms

Vimpat is available in several formulations to accommodate diverse patient needs and preferences. The most common form is the oral tablet, offering a convenient and readily accessible method of administration. These tablets come in various strengths, allowing for precise dosage adjustments based on individual requirements and response to treatment. The availability of different strengths simplifies titration to the optimal therapeutic dose.

In addition to tablets, Vimpat is also available as an oral solution. This liquid formulation is particularly beneficial for patients who have difficulty swallowing tablets or for those requiring more precise dosage adjustments, especially in pediatric populations. The liquid form ensures accurate dosing and can enhance compliance, especially for younger patients or those with swallowing difficulties.

Furthermore, Vimpat is also available in an injectable form for intravenous administration. This route of administration is typically reserved for specific clinical situations where oral administration is not feasible, such as during a period of acute illness or when immediate seizure control is critical. The intravenous formulation allows for rapid absorption and immediate therapeutic effect when needed.

Important Considerations

Before starting Vimpat, it’s essential to inform your doctor about all current medications, including over-the-counter drugs and herbal supplements. Some medications may interact with Vimpat, potentially affecting its efficacy or increasing the risk of side effects. Open communication with your healthcare provider ensures the safest and most effective treatment plan.

Patients should also disclose any pre-existing medical conditions, particularly those affecting the heart, liver, or kidneys. These conditions may influence how the body processes Vimpat, requiring careful dosage adjustments or alternative treatment strategies. This proactive approach minimizes potential risks and ensures individualized care.

Furthermore, individuals considering pregnancy or who are currently pregnant should discuss Vimpat use with their doctor. While Vimpat’s impact on pregnancy is still being studied, careful consideration is needed to weigh potential benefits against potential risks to the developing fetus. This collaborative decision-making process ensures the well-being of both the mother and the child.

Pros and Cons of Vimpat

Like all medications, Vimpat presents both advantages and disadvantages. Understanding these aspects allows for a more informed discussion with your healthcare provider about whether it’s the right treatment option for you. Weighing the potential benefits against potential risks is crucial for making the best decision regarding your epilepsy management.

It is important to remember that individual responses to medication vary considerably. What may be a significant benefit for one person might be less impactful or even problematic for another. Open communication with your doctor about your experiences with Vimpat is essential for optimizing your treatment and managing any potential side effects effectively. Your physician can help determine if Vimpat is the right choice for your particular situation.

Ultimately, the decision of whether or not to use Vimpat should be a collaborative one between you and your healthcare provider. A thorough understanding of both the potential benefits and drawbacks, coupled with open communication, will ensure you receive the best possible care and seizure management strategy. Don’t hesitate to ask questions and express your concerns.

Pros

Vimpat offers several potential advantages for individuals with certain types of epilepsy. One key benefit is its efficacy in managing partial-onset seizures, often providing significant seizure reduction for those who haven’t found adequate control with other medications. This targeted effect can greatly improve quality of life.

Many patients appreciate Vimpat’s relatively tolerable side effect profile compared to some other anti-epileptic drugs. While side effects can occur, they are not universally experienced, and for many, they are manageable. This improved tolerability can lead to better medication adherence and, consequently, better seizure control.

Furthermore, the availability of Vimpat in multiple formulations—tablets, oral solution, and intravenous injection—offers flexibility in administration. This adaptability ensures that patients can find a method of taking the medication that best suits their individual needs and preferences, potentially enhancing compliance with the prescribed treatment regimen. This flexibility can be especially beneficial for patients with swallowing difficulties or those requiring immediate treatment.

Seeking Professional Guidance

Cons

While Vimpat offers significant benefits for many, potential drawbacks should be considered. One is the possibility of experiencing side effects, although their severity and frequency vary widely among individuals. Common side effects can include dizziness, headache, nausea, and diplopia (double vision). These side effects are often mild and transient, but some may require adjustments to the dosage or alternative treatment.

Another potential drawback is the need for careful dosage titration. Starting with a low dose and gradually increasing it as tolerated is crucial to minimize side effects. This process requires close monitoring by a healthcare provider and may take time to achieve optimal therapeutic levels while minimizing adverse events. This careful approach is essential for safe and effective treatment.

Finally, Vimpat’s effectiveness can vary between individuals. While it proves highly beneficial for many, it may not provide sufficient seizure control for everyone. This variability underscores the importance of open communication with your doctor to assess the treatment’s effectiveness and explore alternative options if needed. Regular monitoring and adjustments are key to achieving the best possible outcome.

  • Vimpat™ Tablets 100Mg, 14Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Vimpat™ Tablets 100Mg, 14Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Vimpat™ Tablets 100Mg, 14Pcs Buy Online 6
    [Medical reviewer]

    Dr. David J. Bronster, MD, is a distinguished Professor of Neurology and Neurological Consultant to the Recanati/Miller Transplantation Institute. With an impressive 36-year career in consultative wor...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “VIMPAT™ tablets 100mg, 14pcs”

Your email address will not be published. Required fields are marked

Similar products

LAMICTAL™ tablets 100mg, 30pcs

$170.00
Add to cart

CONVULEX™ syrup 50mg/ml, 100ml

$24.00
Add to cart

CONVALIS™ capsules 300mg, 50pcs

$39.00
Add to cart

KEPPRA™ tablets 500mg, 60pcs

$122.00
Add to cart

KEPPRA™ concentrate for infusion solution 100mg/ml (5ml), 10 vials

$292.00
Add to cart

KEPPRA™ oral solution 100mg/ml (300ml), 1pc

$132.00
Add to cart

KEPPRA™ tablets 250mg, 30pcs

$32.00
Add to cart

KEPPRA™ tablets 500mg, 30pcs

$67.00
Add to cart

KATENA™ capsules 300mg, 100pcs

$103.00
Add to cart

KATENA™ capsules 400mg, 100pcs

$107.00
Add to cart

KATENA™ capsules 400mg, 50pcs

$65.00
Add to cart

CARBAMAZEPINE VELFARM™ tablets 200mg, 50pcs

$10.00
Add to cart

INOVELON™ tablets 200mg, 60pcs

$306.00
Add to cart

INFIRA™ granules for oral solution 500mg, 56pcs

$1,932.00
Add to cart

ZONEGRAN™ capsules 25mg, 14pcs

$43.00
Add to cart

DEPAKINE™ CHRONOSPHERE prolonged-release granules 1000mg, 30 sachets

$64.00
Add to cart

DEPAKINE™ CHRONOSPHERE prolonged-release granules 250mg, 30 sachets

$17.00
Add to cart

DEPAKINE™ ENTERIC 300 enteric tablets 300mg, 100pcs

$29.00
Add to cart

DEPAKINE™ syrup 57.64mg/ml (150ml)

$29.00
Add to cart

DEPAKINE™ CHRONO prolonged-release tablets 300mg, 100pcs

$30.00
Add to cart

GABAGAMMA™ capsules 300mg, 50pcs

$57.00
Add to cart

GABAGAMMA™ capsules 400mg, 50pcs

$65.00
Add to cart

VALPARIN™ XR prolonged-release tablets 300mg, 30pcs

$10.00
Add to cart

VALPARIN™ XR prolonged-release tablets 300mg, 100pcs

$28.00
Add to cart
Select your currency